Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 901–999 of 999
Papadopoulos, K., Lekakis, I., & Nicolaides, E. P. (2017) · SAGE Open Medicine · doi:10.1177/2050312116687707 · Cited by 7
Hong, S., Kim, B., Shin, S., Suh, Y., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., Hong, M., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1173 · Cited by 8
Perry, A., Chung, M. J., Novak, E. L., Krone, R. J., & Brown, D. (2019) · Diagnostic and Prognostic Research · doi:10.1186/s41512-019-0048-7 · Cited by 7
Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., Ijsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., Luca, G. D., & Kedhi, E. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-1293-7 · Cited by 8
Smith, N. J., Miles, B., Cain, M. T., Joyce, L. D., Pearson, P. J., & Joyce, D. L. (2019) · Journal of Cardiac Surgery · doi:10.1111/jocs.14144 · Cited by 7
“Even in the era of percutaneous coronary intervention (PCI), CABG has been borne out as a superior revascularization strategy(1-3); with operative mortality of 1%‐3% and perioperative stroke (CVA) and myocardial infarction (MI) of 1%‐ 3% and 2%‐10%, respectively.(1,2,4) With the rising prevalence of coronary artery di…”
BackgroundNyström, T., James, S. K., Lindahl, B., Östlund, O., Erlinge, D., Herlitz, J. D., Ömerovic, E., Mellbin, L., Alfredsson, J., Fröbert, O., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0590 · Cited by 7
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
Romaguera, R., Salinas, P., Brugaletta, S., Lara, J. G., Fernández, J. F. D., Romero, M., García‐Blas, S., Ocaranza, R., Borde, P., Kockar, M. J., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.01.018 · Cited by 7
Matsoukis, I. L., Καρανάσος, Α., Patsa, C., Anousakis‐Vlachochristou, N., Triantafyllou, K. A., Καντζάνου, Μ., Drakopoulou, M. I., Tsiamis, E. G., Latsios, G., Synetos, A. G., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29247 · Cited by 7
Yamamoto, K., Natsuaki, M., Morimoto, T., Shiomi, H., Takeji, Y., Kadota, K., Imada, K., Toyofuku, M., Kanemitsu, N., Shinoda, E., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.079 · Cited by 7
Hannan, E. L., Wu, Y., Cozzens, K. S., Tamis‐Holland, J. E., Ling, F. S. K., Jacobs, A. K., Venditti, F. J., Berger, P. B., Walford, G. D., & King, S. B. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.03.003 · Cited by 7
Self-citationManagement of Patients With Stable Angina and Type 2 Diabetes
DEEDWANIA, P. C. (2015) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0742 · Cited by 8
Chang, M., Lee, C. W., Ahn, J., Cavalcante, R., Sotomi, Y., Onuma, Y., Han, M., Park, S., Serruys, P. W. J. C., & Park, S. (2017) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26927 · Cited by 7
Ujueta, F., Weiss, E. N., Shah, B., & Sedlis, S. P. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0821-6 · Cited by 7
Coronary bypass: Is it time to take the next step—the routine use of the second arterial graft?
Halkos, M. E., & Guyton, R. A. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.030 · Cited by 7
Gouda, P., Islam, S., Dover, D. C., Kaul, P., Bainey, K. R., & Welsh, R. C. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117477 · Cited by 6
Abizaid, A., Mehran, R., Oliva, A., Chamié, D., Staico, R., Malik, F., Vink, M., Kurniadi, A., Cao, D., Capranzano, P., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02157-9 · Cited by 6
The current status of multi-arterial off-pump coronary artery bypass grafting
Suzuki, T., & Asai, T. (2015) · Surgery Today · doi:10.1007/s00595-015-1124-4 · Cited by 6
“It is well known that diabetic patients experience a survival benefit with CABG as opposed to percutaneous coronary intervention (PCI) [63].”
InfluentialFunctional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment
Scala, A., Erriquez, A., Verardi, F. M., Marrone, A., Scollo, E., Trichilo, M., Durante, A., Tedeschi, D., Cortese, B., Ielasi, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185844 · Cited by 6
“The same method has been used in the external validation of the FREEDOM (Strategies for multivessel revascularization in patients with diabetes), BEST (Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease), and PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients…”
MethodChoice of revascularization strategy for ischemic cardiomyopathy due to multivessel coronary disease
Alzahrani, A., Itagaki, S., Egorova, N., & Chikwe, J. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.03.007 · Cited by 6
Prapas, S. N., Calafiore, A. M., Katsavrias, K. P., Panagiotopoulos, I. A., Linardakis, I. N., Tancredi, F. C., Foschi, M., & Mauro, M. D. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy224 · Cited by 6
Schulman‐Marcus, J., Peterson, K., Banerjee, R., Samy, S. A., & Yager, N. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0706-7 · Cited by 6
National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease
Aguayo, E., Dobaria, V., Sareh, S., Sanaiha, Y., Seo, Y., Hadaya, J. E., & Benharash, P. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.03.120 · Cited by 6
Prasitlumkum, N., Cheungpasitporn, W., Sato, R., Thangjui, S., Thongprayoon, C., Kewcharoen, J., Bathini, T. J., Vallabhajosyula, S., Ratanapo, S., & Chokesuwattanaskul, R. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001167 · Cited by 6
Sumin, A. N., Bezdenezhnykh, N. A., Bezdenezhnykh, A. V., Осокина, А. В., Kuzmina, A. A., Цепокина, А. В., & Барбараш, О. Л. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080802 · Cited by 6
“The FREEDOM study showed that CABG is preferable to PCI in diabetic patients with multivessel coronary disease, reducing mortality and the rate of myocardial infarctions [3], which was confirmed by prospective observation [4] and in subsequent meta-analysis [5].”
ResultLehto, H., Winell, K., Pietilä, A., Niiranen, T., Lommi, J., & Salomaa, V. V. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab065 · Cited by 9
Torabi, A. J., Mshelbwala, F. S., Hugenberg, D. W., Kovacs, R. J., & Kreutz, R. P. (2022) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30108 · Cited by 7
Pasierski, M., Staromłyński, J., Finke, J., Litwinowicz, R. A., Filip, G., Kowalówka, A. R., Wańha, W., Kołodziejczak, M. M., Piekuś-Słomka, N., Łoś, A., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.910811 · Cited by 6
“However, surgical revascularization is still the first-choice procedure in high-risk non-acute MI patients, specifically those with diabetes (7) and intermediate-to-high anatomical complexity coronary disease (8).”
BackgroundMethodKim, H., Kang, D., Ahn, J.-M., Lee, J., Choi, Y., Hur, S., Park, H.-J., Tresukosol, D., Kang, W.-C., Kwon, H.-M., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.07.028 · Cited by 5
Dokollari, A., Gemelli, M., Sicouri, S., Gray, W. A., Shapiro, T. A., McGeehin, F. C., Badri, M., Coady, P. M., Gnall, E., Caroline, M., et al. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.12.054 · Cited by 6
Wickbom, A., Fengsrud, E., Alfredsson, J., Engdahl, J., Kalm, T., & Ahlsson, A. (2024) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2024.2347297 · Cited by 8
“In the Freedom trial, comparing CABG with PCI in diabetic patients with multi-vessel coronary artery disease, the stroke incidence at 5 years was 5.2% in the CABG group and 2.4% in the PCI group [23].”
InfluentialNogueira-Garcia, B., Vilela, M., Oliveira, C., Caldeira, D., Martins, A. M. M. A. M., & Menezes, M. N. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050506 · Cited by 8
Sumin, A. N., Bezdenezhnykh, N. A., Bezdenezhnykh, A. V., Ivanov, S. V., Belik, E. V., & Барбараш, О. Л. (2014) · Diabetes Mellitus · doi:10.14341/dm2014425-34 · Cited by 6
Capodanno, D., Capranzano, P., & Tamburino, C. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.077 · Cited by 6
Conduits for Coronary Bypass: Strategies
Barner, H. B. (2013) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/kjtcs.2013.46.5.319 · Cited by 6
“FREEDOM [2].”
InfluentialPercutaneous coronary intervention
Ludman, P. (2014) · Medicine · doi:10.1016/j.mpmed.2014.06.005 · Cited by 6
Bioresorbable Polymers and Stent Devices
Dehghani, P. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0510-1 · Cited by 6
Papadopoulos, K., Lekakis, I., & Nicolaides, E. P. (2017) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401711010028 · Cited by 6
“In contrast, in the FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease) trial of 1,900 diabetic patients with multivessel CAD treated with PCI or CABG, no significant interaction was observed between the revascularization strategy and the SS for 1…”
MethodAlcohol attenuates myocardial ischemic injury
Scrimgeour, L. A., Potz, B. A., Elmadhun, N. Y., Chu, L. M., & Sellke, F. W. (2017) · Surgery · doi:10.1016/j.surg.2017.04.014 · Cited by 6
“Furthermore, patients with diabetes often have other comorbidities even beyond those of metabolic syndrome, rendering them even greater risk for coronary revascularization and poorer candidates for percutaneous coronary intervention.(4) Besides tight glucose control, there are few therapeutic preventative options for…”
BackgroundLee, C. H., Ahn, J., Lee, P. H., Han, M., Kang, S. H., Kang, S., Lee, S., Kim, Y., Lee, C. W., Park, S., et al. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000497 · Cited by 6
Birkner, K., Hudzik, B., & Gąsior, M. (2017) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2017.68744 · Cited by 6
Mina, G. S., Watti, H., Soliman, D., Shewale, A. R., Atkins, J., Reddy, P. C., & Dominic, P. S. (2018) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2018.01.003 · Cited by 6
A Review of Coronary Artery Bypass Grafting in the Indigenous Australian Population
Wiemers, P. D., Fraser, J. F., Marney, L., Yadav, S., & Tam, R. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.08.007 · Cited by 7
Heart failure: A preventable and treatable complication of type 2 diabetes
Straw, S., Witte, K. K., & Kearney, M. T. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12930 · Cited by 7
“The future revasculization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial demonstrated that, in patients with diabetes, CABG resulted in improved mortality and fewer cardiac events than PCI, but only 3% of these patients had HFrEF.(19) The surgical treatment fo…”
BackgroundMieres, J., Rodríguez, A. E., Fernández‐Pereira, C., & Ascarrunz, D. (2020) · Future Cardiology · doi:10.2217/fca-2020-0033 · Cited by 6
Acute coronary syndrome in diabetes mellitus: features of pathogenesis, course and therapy
Kokozheva, M. A., Марданов, Б. У., & Мамедов, М. Н. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20212402189 · Cited by 6
Coronary revascularization in patients with stable coronary disease and diabetes mellitus
Bhat, S. Z., Yatsynovich, Y., & Sharma, U. C. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211002469 · Cited by 7
Hinojosa-Gonzalez, D. E., Bueno‐Gutierrez, L. C., Salan‐Gomez, M., Tellez‐Garcia, E., Ramírez-Mulhern, I., Sepulveda-Gonzalez, D., Ramonfaur, D., Roblesgil‐Medrano, A., & Flores-Villalba, E. A. (2022) · The Journal of Cardiovascular Surgery · doi:10.23736/s0021-9509.22.12163-4 · Cited by 6
Neumann, F. (2022) · Herz · doi:10.1007/s00059-022-05132-8 · Cited by 7
Ammirati, E., Guida, V., Latib, A., Moroni, F., Arioli, F., Scotti, I., Rimoldi, O. E., Colombo, A., & Camici, P. G. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0126-x · Cited by 6
“In a recent trial, the Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal management of Multivessel Disease (FREEDOM) [22], CABG was associated with reduction of all-cause death in patients with multivessel disease and diabetes compared with PCI.”
MethodA novel approach to ischemic mitral regurgitation (IMR).
Scoville, D. H., & Boyd, J. H. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2225-319x.2015.08.06 · Cited by 6
Development of a saphenous vein harvest model for simulation-based assessment
Duffy, M. C., Ibrahim, M., & Lachapelle, K. J. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.07.042 · Cited by 6
Zheng, Z., Cheng, Z. C., Wang, S. P., Li, S., Wang, J., Peng, H. Y., Wu, Z., Li, W. Z., Lv, Y., Tian, J., et al. (2019) · Cardiology Research and Practice · doi:10.1155/2019/6857232 · Cited by 6
Adventitial Collagen Crosslink Reduces Intimal Hyperplasia in a Rabbit Arteriovenous Graft Model
Liu, C., Yu, W., Chen, D., Shi, Y., Li, Z., & Gu, C. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.047 · Cited by 6
Fuster, V. (2016) · European Cardiology Review · doi:10.15420/ecr.2016.11.2.123 · Cited by 6
Self-citationBilateral internal thoracic arteries: what is the State of the ART?
Yanagawa, B., Verma, S., & Puskas, J. D. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000431 · Cited by 6
Lies, damned lies, and statistics
Kurlansky, P. A. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.03.051 · Cited by 6
Coronary Artery Bypass Graft Surgery Remains the Standard of Care for Patients With Diabetes
Moss, E., Alam, M., Ballantyne, C. M., & Puskas, J. D. (2013) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2013.07.007 · Cited by 5
Optimal medical therapy vs. revascularization on long-term LV function
Sidhu, M. S., & Boden, W. E. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht297 · Cited by 6
Stress MPI, coronary CTA, and multimodality for subsequent risk analysis
Naya, M., & Tamaki, N. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0400-z · Cited by 7
Garratt, K. N. (2014) · Circulation · doi:10.1161/circulationaha.114.013678 · Cited by 6
Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions
Kahlon, R. S., & Armstrong, E. J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010609 · Cited by 6
Hayanga, J. W. A., Vopporu, S., Bham, N. S., Hansen, A. J., Mehaffey, J. H., Rajjoub, H., Reddy, S., Badhwar, V., & Lamb, J. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2025.09.033 · Cited by 5
Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
Madhavan, M. V., Gregson, J., Redfors, B., Chen, S., Sabik, J., Fujino, A., Kotinkaduwa, L., Karmpaliotis, D., Moses, J. W., Ben-Yehuda, O., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.075875 · Cited by 4
Elección de intervención coronaria percutánea o bypass en la enfermedad coronaria multivaso
Buchanan, G. L., Giustino, G., & Chieffo, A. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.08.017 · Cited by 5
Coronary Artery Bypass Surgery: Evidence-Based Practice
Thuan, P. Q., Chuong, P. T. V., Nam, N. H., & Định, N. H. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000621 · Cited by 9
Clinical practice guidelines: ensuring quality through international collaboration
Milojevic, M., Nikolić, A., Bakaeen, F. G., & Myers, P. O. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae237 · Cited by 5
Myocardial Revascularization in Patients with Diabetes and Heart Failure—A Narrative Review
Živković, S., Mandić, A., Krupnikovic, K. S., Obradović, A. D., Mišević, V., Farkić, M., Ilić, I., Tesic, M. B., Aleksandric, S. B., Juričić, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073398 · Cited by 7
“This study also reported a significant decrease in all-cause mortality, myocardial infarction, and repeat revascularization separately, as well as an increase in stroke in the CABG group compared with the PCI group [55].”
InfluentialRodríguez, A. E. (2013) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2012.11.002 · Cited by 5
“In addition, the increase in hard cardiac events beyond one year with PCI appears to be a common finding in both FREEDOM and SYNTAX trials [9,10,13].”
BackgroundResultMost Important Outcomes Research Papers on Treatment of Stable Coronary Artery Disease
Bikdeli, B., Ranasinghe, I., Chen, R., Gupta, A., Lampropulos, J. F., Kulkarni, V., Mody, P. S., Dharmarajan, K., & Editor, F. T. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000310 · Cited by 6
Marso, S. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00023-6 · Cited by 5
Барбараш, О. Л., Ganyukov, V. I., Tarasov, R. S., & Barbarash, L. S. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4210 · Cited by 5
Review on the numerical investigations of mass transfer from drug eluting stent
Song, J., Kouidri, S., & Bakir, F. (2021) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2021.06.010 · Cited by 5
Revascularization Strategies in Patients with Diabetes and Acute Coronary Syndromes
Scudeler, T. L., Godoy, L. C., Hoxha, T., Kung, A., Moreno, P., & Farkouh, M. E. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01646-z · Cited by 8
Self-citationHansen, K. N., Noori, M., Christiansen, E. H., Kristiansen, E. B., Mæng, M., Zwisler, A., Borregaard, B., Søgaard, R., Veien, K. T., Junker, A., et al. (2022) · Diabetes and Vascular Disease Research · doi:10.1177/14791641221113788 · Cited by 5
“However, the development of the drug-eluting stents (DES) has significantly reduced the risk.5,22,27 Cardiovascular disease in diabetic patients is more likely to consist of complex, multi-vessel lesions, small vessels with diffuse disease and containing more calcification, necrotic core and thin-cap atheroma.11,28 St…”
BackgroundCABG versus PCI: What is the optimal strategy for multi-vessel disease?
Kumar, A., Priya, Khatri, G., & Hasan, M. M. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104354 · Cited by 5
Watanabe, H., Yamamoto, K., Shiomi, H., Morimoto, T., Kato, E. T., Matsumura, Y., Nakatsuma, K., Takeji, Y., Yaku, H., Yamamoto, E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267906 · Cited by 9
“In the new-generation DES era, there was only one moderate sized RCT comparing PCI with CABG, although RCTs in the first-generation DES era have clearly demonstrated benefit of CABG over PCI in patients with complex multi-vessel CAD in terms of survival, myocardial infarction, and repeat revascularization [1, 2].”
MethodRobotic Coronary Revascularization is Feasible and Safe
Al‐Mulla, A. W., Sarhan, H. H. T., Abdalghafoor, T., Al-Balushi, S. K., Kahlout, M. I. E., Tbishat, L., Alwaheidi, D. F., Maksoud, M., Omar, A. S., Ashraf, S., et al. (2022) · Heart Views · doi:10.4103/heartviews.heartviews_53_22 · Cited by 5
“[3,4] Placement of the LIMA graft to the LAD artery has been traditionally considered to provide a survival benefit in patients with CAD.”
Franco, D., Goslar, T., Radšel, P., LUCA, N. D., Mancusi, C., Barbato, E., & Noč, M. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad012 · Cited by 5
van der Merwe, J., & Casselman, F. P. A. (2023) · Journal of Visualized Surgery · doi:10.21037/jovs-22-40 · Cited by 5
Right-Sided Minimally Invasive Direct Coronary Artery Bypass: Clinical Experience and Perspectives
Hecker, F., von Zeppelin, M., Linden, A. V., Scholtz, J., Fichtlscherer, S., Hlavička, J., Walther, T., & Holubec, T. (2023) · Medicina · doi:10.3390/medicina59050907 · Cited by 5
“Additionally, LITA-LAD could provide favorable long-term data compared to PCI in multivessel disease in the BEST and the FREEDOM trials [27,28].”
MethodDealing With Nonproportional Hazards in Coronary Revascularisation Studies
Godoy, L. C., Ko, D. T., Farkouh, M. E., Shah, B. R., & Austin, P. C. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.07.014 · Cited by 5
Self-citationPan, S., Yang, J., Teng, N.-C., Chen, Y., Wang, S., Lee, C.-L., Chen, K.-L., Chiu, Y., Hsu, S., Peng, Y., et al. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100768 · Cited by 5
“The duration of the index hospitalization was longer in the CABG group (CABG 20 [14-30] days vs PCI with DES 3 [2-8] days; P < 0.001, Table S1).”
BackgroundInfluentialLee, G. S., Malik, A., Vervoort, D., Tam, D. Y., Marquis‐Gravel, G., Redfors, B., Gaudino, M. F. L., & Fremes, S. E. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.05.023 · Cited by 5
Makortoff, L., Then, K. L., Dutchak, M., Lin, M., Youngson, E. R. E., & Harten, C. (2024) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.4620 · Cited by 5
“4,5 Thus, evidence-based medication therapy remains a crucial aspect of secondary prevention in this population.”
Patel, P. M., Arrington, R. L., Jonsson, A. A., Wei, J. W., Binongo, J., Devireddy, C. M., Nicholson, W. J., Jaber, W. A., Rinfret, S., & Halkos, M. E. (2025) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1177/15569845241311292 · Cited by 5
Lee, B. J., Herbison, P., & Wong, C. (2014) · 老年心脏病学杂志:英文版 · doi:10.3969/j.issn.1671-5411.2014.01.009 · Cited by 5
Buchanan, G. L., Chieffo, A., & Colombo, A. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.09.003 · Cited by 6
Piek, J. J., Claessen, B. E. P. M., Davies, J. E., & Escaned, J. (2015) · Open Heart · doi:10.1136/openhrt-2015-000308 · Cited by 5
Key Advances in Clinical Cardiology
Connolly, M., & Menown, I. B. A. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0024-5 · Cited by 5
Interventions for Coronary Artery Disease (Surgery vs Angioplasty) in Diabetic Patients
Hoffman, D. M., & Tranbaugh, R. F. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.011 · Cited by 5
Anastomotic devices in coronary artery surgery: it is about the anastomosis?
Patel, N. C., & Hemli, J. M. (2013) · Multimedia Manual of Cardio-Thoracic Surgery · doi:10.1093/mmcts/mmt019 · Cited by 5
Appropriateness of Percutaneous Coronary Intervention: A Review
Summers, M. R., & Patel, M. R. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0379-x · Cited by 5
Xhepa, E., Tada, T., Kufner, S., Ndrepepa, G., Byrne, R. A., Kreutzer, J., Ibrahim, T., Tiroch, K. A., Valgimigli, M., Tölg, R., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26645 · Cited by 5
Impact of diabetes duration on 3-year clinical outcomes following coronary revascularization
Gao, H.-Y., Zhang, E., Liu, Q., Gu, H., Zhang, H., Zheng, Z., Yang, Y., Gao, R.-L., & Wu, Y. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000441 · Cited by 5
Linder, R., Zeidler, J., Verheyen, F., von der Schulenburg, J. M. G., Haverich, A., & Schilling, T. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-017-0924-4 · Cited by 5
Lüscher, T. F. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx631 · Cited by 5
Graft patency in diabetic patients and the discomfort of thought
Kurlansky, P. A. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.12.158 · Cited by 5
Ruel, M., Sun, L. Y., & Gaudino, M. F. L. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.04.088 · Cited by 5
Cummings, I., Lucchese, G., Garg, S., Soni, M. K., Majid, A. F., Marczin, N., Panoulas, V. F., & Raja, S. G. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.03.008 · Cited by 5
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.